美国显影剂和放射性药物市场：Medtech 360

Contrast Agents and Radiopharmaceuticals | Medtech 360 | Market Insights | United States

出版日期: 2024年06月25日 | 出版商:

Clarivate | 英文 | 商品交期: 最快1-2个工作天内

价格

简介目录

预计美国显影剂和放射性药物市场在整个预测期内将出现温和成长。 PET 和 MRI 检查数量的增加以及 CEUS 和 PET 检查中显影剂使用的扩大推动了市场成长。然而，由于人们仍然担心某些方式中的钆和辐射暴露，因此市场受到一定程度的限制。此外，向「基于价值的医学」的转变可能会对某些手术造成障碍，反而有利于提供最高水准的精确度和清晰可视化的手术。未来的市场发展将由目前正在开发或临床试验中的新型显影剂的推出，以及FDA对现有显影剂核准推动。

本报告提供了 2019-2033 年美国显影剂和放射性药物市场的全面资料和分析。

FDA核准PSMA PET 显影剂的数量正在逐渐增加。

哪些 PET 显影剂获得 FDA核准？
这些 PSMA PET 显影剂有哪些优点？
它被核准用于哪些适应症？

製造商正在积极参与显影剂产品的临床评估。

哪些类型的显影剂正在接受临床评估？
与现有显影剂相比有哪些优势？

FDA 扩大了在放射治疗中使用 CEUS 的核准。

该核准适用什么程序？未来可能会核准哪些额外的治疗方法？
哪些显影剂获得 FDA核准？
FDA 的这些核准将如何改变竞争格局？

对钆滞留效应的担忧似乎会对造影增强 MRI 的使用产生负面影响。

ACO、健康网络和医生对钆保留的最新见解有何反应？
锁状GBCA 和大环 GBCA 之间的主要差异是什么？未来这些产品的市场需求将如何改变？
其他显像模式会主导造影增强 MRI 程式的市场吗？
哪些公司（及相关产品）将受益于向大环 GBCA 的转变？

The US contrast agents and radiopharmaceutical market will see moderate growth over the forecast period. Market growth will be driven by rising PET and MRI procedure volumes, and the expanding use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities. Additionally, the shift toward value-based care will act as a barrier for certain procedures, favoring those that offer the highest levels of accuracy and clarity in visualization instead. Moving forward, market growth will be driven by the introduction of new contrast agents currently in development or undergoing clinical trials, along with FDA approvals for expanded indications of existing contrast agents.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for contrast agents and radiopharmaceuticals in the US from 2019 through 2033.

There has been a gradual increase in the number FDA approvals for PSMA PET imaging agents.

Which PET imaging agents have received FDA approval?
What advantages do these PSMA PET imaging agents offer?
What indications are they approved for?

Manufacturers are actively engaging in ongoing clinical evaluation of their contrast agent products.

Which contrast agent products are under clinical evaluation?
What advantage do they offer over the existing contrast agents in the market.

The FDA expanded approval for the use of CEUS in radiology procedures.

What type of procedures does this approval extend to? What additional procedures could be approved in the future?
Which contrast agents have received FDA approval?
How will these FDA approvals change the competitive landscape.

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
Will other imaging modalities cannibalize contrast-enhanced MRI procedures?
Which companies (and associated products) will benefit from the shift to macrocyclic GBCAs?

United States

Abstract

Executive Summary

COVID-19 Updates
Market Highlights
Competitive Highlights
Market Developments
Procedures and Products Covered

Key Report Updates

Contrast Agent and Radiopharmaceutical Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- Cardinal Health
- GE Healthcare
- Bracco Group
- Lantheus Holdings
- Bayer Healthcare
- Other Key Competitors
- Factors Affecting All Competitors
Market Developments

Radiopharmaceutical Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US Radiopharmaceutical Market Competitive Insights

CT and X-Ray Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US CT and X-Ray Contrast Agent Market Competitive Insights

MRI Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US MRI Contrast Agent Market Competitive Insights
- Factors Affecting All Competitors

Ultrasound Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US Ultrasound Contrast Agent Market Competitive Insights

Appendix

Abbreviations
Bibliography

Tables and Figures

Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2023 and 2033
Competitive Insights
Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2023
Companies Mentioned
Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
US Contrast Agent and Radiopharmaceutical Market Drivers
US Contrast Agent and Radiopharmaceutical Market Limiters
Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2019-2033
Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2023
Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
Cardinal Health Competitive Insights
GE Healthcare Competitive Insights
Bracco Group Competitive Insights
Lantheus Holdings Competitive Insights
Bayer Healthcare Competitive Insights
Competitive Insights for Other Key Competitors
Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
US Radiopharmaceutical Market Drivers
US Radiopharmaceutical Market Limiters
Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Radiopharmaceutical Market Growth, by Product Type, US, 2020-2033
Nuclear Medicine System Installed Base, by Product Type, US, 2019-2033
Radiopharmaceutical Revenue Market Shares, US, 2023
Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
US CT and X-Ray Contrast Agent Market Drivers
US CT and X-Ray Contrast Agent Market Limiters
CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2020-2033
CT and X-Ray System Installed Base, by Product Type, US, 2019-2033
CT Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
CT Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
X-Ray, Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
US MRI Contrast Agent Market Drivers
US MRI Contrast Agent Market Limiters
MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
MRI Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
MRI System Installed Base, US, 2019-2033
MRI Contrast Agent Revenue Market Shares, US, 2023
MRI Contrast Agent Revenue Market Shares, US, 2023
US Ultrasound Contrast Agent Market Drivers
US Ultrasound Contrast Agent Market Limiters
Ultrasound Contrast Agent Market, US (USD), 2019-2033
Ultrasound Contrast Agent Market, US (USD), 2019-2033
Ultrasound Contrast Agent Revenue Market Shares, US, 2023
Ultrasound Contrast Agent Revenue Market Shares, US, 2023